Abacus Health Products announced a round of purchase orders from different retailers for its CBDMEDIC line of “topical pain medications.”
Abacus Health Products (CSE:ABCS) announced a round of purchase orders from different retailers for its CBDMEDIC line of “topical pain medications.”
As quoted in the press release:
These new orders from five US retail chains, including CVS Pharmacy, Weis Markets, and Pharmacare Inc., bring CBDMEDIC products to over 1,100 pharmacy and supermarket retail locations throughout the country.
“These new purchase orders demonstrate strong momentum and the successful execution of our retail growth strategy,” said Perry Antelman, CEO of Abacus. “Moving forward, we continue to identify and pursue opportunities to further expand the availability of our range of CBDMEDIC products. We are providing new and innovative products for consumers seeking topical pain relief and therapeutic skincare treatment.”